Artikel i dags-/nyhetstidning2023
Sveriges utsläpp måste minska nu, regeringen
Skelton, Alasdair; Hajdu, Flora; Wolrath Söderberg, Maria.
Publikationer
2023
Forskningsartikel2023Vetenskapligt granskadÖppen tillgång
A randomized, triple-blinded controlled clinical study with a novel disease-modifying drug combination in equine lameness-associated osteoarthritis
Skiöldebrand, Eva; Adepu, Saritha; Lützelschwab, Claudia et al.
Forskningsartikel2023Vetenskapligt granskadÖppen tillgång
Salivary biglycan-neo-epitope-BGN262: A novel surrogate biomarker for equine osteoarthritic sub-chondral bone sclerosis and to monitor the effect of short-term training and surface arena
Adepu, Saritha; Lord, M.; Hugoh, Z. et al.
Forskningsartikel2023Vetenskapligt granskadÖppen tillgång
Serum nerve growth factor in horses with osteoarthritis-associated lameness
Kendall, Anna; Lutzelschwab, Claudia; Lundblad, Johan et al.
Forskningsartikel2023Vetenskapligt granskadÖppen tillgång
Bone Biomarker in Feedlot Cattle from Two Different Production Systems
Lützelschwab, Claudia; Adepu, Saritha; Ekman, Stina et al.
2022
Forskningsartikel2022Vetenskapligt granskad
Evaluation of the efficacy of polymeric antigen BLSOmp31 formulated in a new cage-like particle adjuvant (ISPA) administered by parenteral or mucosal routes against Brucella ovis in BALB/c mice
Celeste Moran, Maria; Paula Dominguez, Maria; Bence, Angel Ricardo et al.
2021
Forskningsartikel2021Vetenskapligt granskadÖppen tillgång
Development of a 3-transcript host expression assay to differentiate between viral and bacterial infections in pigs
Hjertner, Bernt; Lutzelschwab, Claudia; Schieck, Elise et al.
Forskningsartikel2021Vetenskapligt granskad
Polymeric antigen BLSOmp31 formulated with class B CpG-ODN in a nanostructure (BLSOmp31/CpG-ODN/Coa-ASC16) administered by parenteral or mucosal routes confers protection against Brucella ovis in Balb/c mice
Celeste Moran, Maria; Ricardo Bence, Angel; Sanchez Vallecillo, Maria Fernanda et al.